These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 18577180

  • 41. The genetic basis of fluconazole resistance development in Candida albicans.
    Morschhäuser J.
    Biochim Biophys Acta; 2002 Jul 18; 1587(2-3):240-8. PubMed ID: 12084466
    [Abstract] [Full Text] [Related]

  • 42. A Zinc Cluster Transcription Factor Contributes to the Intrinsic Fluconazole Resistance of Candida auris.
    Mayr EM, Ramírez-Zavala B, Krüger I, Morschhäuser J.
    mSphere; 2020 Apr 22; 5(2):. PubMed ID: 32321822
    [Abstract] [Full Text] [Related]

  • 43. The evaluation of the overexpression of the ERG-11, MDR-1, CDR-1, and CDR-2 genes in fluconazole-resistant Candida albicans isolated from Ahvazian cancer patients with oral candidiasis.
    Maheronnaghsh M, Teimoori A, Dehghan P, Fatahinia M.
    J Clin Lab Anal; 2022 Feb 22; 36(2):e24208. PubMed ID: 34997991
    [Abstract] [Full Text] [Related]

  • 44. The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans.
    Alarco AM, Raymond M.
    J Bacteriol; 1999 Feb 22; 181(3):700-8. PubMed ID: 9922230
    [Abstract] [Full Text] [Related]

  • 45. Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Lopez-Ribot JL, McAtee RK, Lee LN, Kirkpatrick WR, White TC, Sanglard D, Patterson TF.
    Antimicrob Agents Chemother; 1998 Nov 22; 42(11):2932-7. PubMed ID: 9797228
    [Abstract] [Full Text] [Related]

  • 46. Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole Resistance.
    Doorley LA, Rybak JM, Berkow EL, Zhang Q, Morschhäuser J, Rogers PD.
    Antimicrob Agents Chemother; 2022 Jul 19; 66(7):e0028922. PubMed ID: 35699442
    [Abstract] [Full Text] [Related]

  • 47. Mrr1 regulation of methylglyoxal catabolism and methylglyoxal-induced fluconazole resistance in Candida lusitaniae.
    Biermann AR, Demers EG, Hogan DA.
    Mol Microbiol; 2021 Jan 19; 115(1):116-130. PubMed ID: 33319423
    [Abstract] [Full Text] [Related]

  • 48. A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains.
    Kusch H, Biswas K, Schwanfelder S, Engelmann S, Rogers PD, Hecker M, Morschhäuser J.
    Mol Genet Genomics; 2004 Jun 19; 271(5):554-65. PubMed ID: 15114480
    [Abstract] [Full Text] [Related]

  • 49. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
    Reis de Sá LF, Toledo FT, Gonçalves AC, Sousa BA, Dos Santos AA, Brasil PF, Duarte da Silva VA, Tessis AC, Ramos JA, Carvalho MA, Lamping E, Ferreira-Pereira A.
    Antimicrob Agents Chemother; 2017 Jan 19; 61(1):. PubMed ID: 27821447
    [Abstract] [Full Text] [Related]

  • 50. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.
    Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA.
    Infect Immun; 2003 Aug 19; 71(8):4333-40. PubMed ID: 12874310
    [Abstract] [Full Text] [Related]

  • 51. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
    Chen CG, Yang YL, Tseng KY, Shih HI, Liou CH, Lin CC, Lo HJ.
    Fungal Genet Biol; 2009 Sep 19; 46(9):714-20. PubMed ID: 19527793
    [Abstract] [Full Text] [Related]

  • 52. Acquired resistance or tolerance? - in search of mechanisms underlying changes in the resistance profile of Candida albicans and Candida parapsilosis as a result of exposure to methotrexate.
    Góralska K, Szybka M, Karuga FF, Pastuszak-Lewandoska D, Brzeziańska-Lasota E.
    J Mycol Med; 2024 Jun 19; 34(2):101476. PubMed ID: 38507825
    [Abstract] [Full Text] [Related]

  • 53. Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation.
    Branco J, Ryan AP, Pinto E Silva A, Butler G, Miranda IM, Rodrigues AG.
    Clin Microbiol Infect; 2022 Dec 19; 28(12):1655.e5-1655.e8. PubMed ID: 36028086
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
    Jin L, Cao Z, Wang Q, Wang Y, Wang X, Chen H, Wang H.
    BMC Infect Dis; 2018 Apr 10; 18(1):162. PubMed ID: 29631565
    [Abstract] [Full Text] [Related]

  • 56. Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps.
    Zhang H, Gao A, Li F, Zhang G, Ho HI, Liao W.
    Yakugaku Zasshi; 2009 May 10; 129(5):623-30. PubMed ID: 19420894
    [Abstract] [Full Text] [Related]

  • 57. Research of Mrr1, Cap1 and MDR1 in Candida albicans resistant to azole medications.
    Feng W, Yang J, Yang L, Li Q, Zhu X, Xi Z, Qiao Z, Cen W.
    Exp Ther Med; 2018 Feb 10; 15(2):1217-1224. PubMed ID: 29434708
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR, Lin YH, Niimi K, Lamping E, Keniya M, Niimi M, Tanabe K, Monk BC, Cannon RD.
    Antimicrob Agents Chemother; 2008 Nov 10; 52(11):3851-62. PubMed ID: 18710914
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.